Dextromethorphan and guaifenesin use should be monitored carefully in people with "very poor metabolizer" CYP2D6 enzyme concentrations and people who are sedated. This mix medication contains a massive median toxic dose (TD50) to median helpful dose (ED50) ratio (or therapeutic index) in these patients. Again and again this drug is https://k2paperforsale66542.nizarblog.com/30308897/new-step-by-step-map-for-dextromethorphan-dxm-for-sale-in-europe